Market Research NewsNews

Global Crohn’s Disease Market by 2026 | Key Players- Pfizer Inc. (US), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), UCB S.A. (Belgium), Ferring B.V. (Switzerland), Tillotts Pharma AG (Switzerland)

The Global Crohn’s Disease Market research report gives pin point analysis of changing market patterns, its components and keeps the customers before their contenders. It gives specific outlines and exemplified SWOT analysis of significant market segments.

Get a Free Sample Copy of the Report

Global Crohn’s Disease Market is expected to rise gradually to an estimated value of USD 13.52 billion by 2026, registering a CAGR of 4.1% in the forecast period of 2019-2026 with the annual sales of USD 9.8 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

Market Definition: Global Crohn’s Disease Market

Crohn’s Disease is also called as inflammatory bowel disease (IBD), as it causes inflammation of the gastro-intestinal tract resulting into abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. Crohn’s disease is a rare disease, caused by a combination of factors involving genetics, the environment, and an overactive immune system.

According to the CDC, 3 million people in US and are suffering from Crohn’s Disease in 2015. Almost more than half of these cases could have been avoided with the availability of proper medical equipment and devices for healthcare procedures. This significant number is expected to act as a driver to the market growth.

Key Market Competitors: Global Crohn’s Disease Market

  • AbbVie Inc. (US),
  • Allergan, Inc. (US),
  • Bayer AG (Germany),
  • Bristol-Myers Squibb (US),
  • Boehringer Ingelheim GmbH (Germany),
  • Hoffmann-La Roche (Switzerland),
  • Eli Lilly and Co. (US),
  • GlaxoSmithKline plc (UK),
  • Janssen Biotech, Inc. (US),
  • Johnson & Johnson (US),
  • Novartis International AG (Switzerland),
  • Pfizer Inc. (US),
  • Sanofi (France),
  • Takeda Pharmaceutical Company Limited (Japan),
  • UCB S.A. (Belgium),
  • Ferring B.V. (Switzerland),
  • Tillotts Pharma AG (Switzerland)

Make an Inquiry for purchasing this report @

Market Drivers:

  • High prevalence rate of the disease will drive the market.
  • Prompt diagnosis of the disease and individual treatment of each symptom of the IBD can help in the growth of the market.

Market Restraints:

  • Lack of awareness about the available treatment options among the population that belongs to middle and low-income economies can hinder the market growth.
  • Biologics going off-patent can increase the biosimilar competition that can affect the growth of the market.

Segmentation: Global Crohn’s Disease Market

By Procedures

  • Colonoscopy
  • Flexible Sigmoidoscopy
  • Computerized Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Capsule Endoscopy
  • Double-Balloon Endoscopy
  • Small Bowel Imaging

By Therapeutic Type

  • Non-surgical
      • Antibiotics
      • Anti-Diarrheal
      • Immune System Suppressors
      • Pain Relievers
      • Anti-Inflammatory Drugs
  • Surgical

By Geography

North America, South America, Europe, Asia-Pacific, Middle East and Africa

Competitive Analysis: Global Crohn’s Disease Market

Global Crohn’s disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Crohn’s disease market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Major Topics Covered in this Report:

Chapter 1 Study Coverage

Chapter 2 Executive Summary

Chapter 3 Market Size by Manufacturers

Chapter 4 Production by Regions

Chapter 5 Consumption by Regions

Chapter 6 Market Size by Type

Chapter 7 Market Size by Application

Chapter 8 Manufacturers Profiles

Chapter 9 Production Forecasts

Chapter 10 Consumption Forecast

Chapter 11 Upstream, Industry Chain and Downstream Customers Analysis

Chapter 12 Opportunities & Challenges, Threat and Affecting Factors

Chapter 13 Key Findings

Chapter 14 Appendix

Browse Detailed TOC, Tables and Figures @

Reasons to Purchase this Report

  • Current and future of global Crohn’s disease market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Key points for analysis

  • To gain information about the top players in this industry, their product portfolios, and their key strategies.
  • Drivers and restrains of the market
  • To get a comprehensive overview of the Xyz market.
  • Key developments in the market
  • Market volume
  • Potential and niche segments/regions exhibiting promising growth

The research report provides in-depth analysis on:

  • The estimated growth rate along with size and share of the Crohn’s Disease Diagnostic and Therapeutic Market during the forecast period.
  • The prime factors expected to drive the Crohn’s Disease Diagnostic and Therapeutic Market for the estimated period.
  • The major market leaders and what has been their business winning strategy for success so far.
  • Significant trends shaping the growth prospects of the Crohn’s Disease Diagnostic and Therapeutic Market.

Looking for more insights from this report? click the link below @


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *